We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 6.25%
2 Industrials 4.6%
3 Consumer Discretionary 4.31%
4 Healthcare 4.26%
5 Financials 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PDSB icon
4301
PDS Biotechnology
PDSB
$14.1M
$6K ﹤0.01%
+2,717
New +$7.62K
PHYS icon
4302
Sprott Physical Gold
PHYS
$16B
$6K ﹤0.01%
400
+200
+100% +$3.05K
RDCM icon
4303
Radcom
RDCM
$171M
$6K ﹤0.01%
591
+200
+51% +$1.81K
SANW
4304
DELISTED
S&W Seed Co
SANW
$6K ﹤0.01%
+135
New +$6.63K
SCHK icon
4305
Schwab 1000 Index ETF
SCHK
$5.93B
$6K ﹤0.01%
370
-45,956
-99% -$750K
SCYX icon
4306
SCYNEXIS
SCYX
$48.2M
$6K ﹤0.01%
164
-511
-76% -$25K
SELF
4307
Global Self Storage
SELF
$58.8M
$6K ﹤0.01%
1,499
+1,100
+276% +$4.29K
SINT icon
4308
SiNtx Technologies
SINT
$10.5M
0
SLV icon
4309
iShares Silver Trust
SLV
$31.9B
$6K ﹤0.01%
+300
New +$6.82K
SOHU
4310
Sohu.com
SOHU
$368M
$6K ﹤0.01%
300
+200
+200% +$3.47K
TBF icon
4311
ProShares Short 20+ Year Treasury ETF
TBF
$106M
$6K ﹤0.01%
+400
New +$6.08K
TFII icon
4312
TFI International
TFII
$11.9B
$6K ﹤0.01%
134
-129
-49% -$5.43K
TRVI icon
4313
Trevi Therapeutics
TRVI
$2.56B
$6K ﹤0.01%
+1,407
New +$6.61K
VNCE icon
4314
Vince Holding Corp
VNCE
$78.5M
$6K ﹤0.01%
1,220
VTLE
4315
DELISTED
Vital Energy
VTLE
$6K ﹤0.01%
607
-748
-55% -$10.4K
WHF icon
4316
WhiteHorse Finance
WHF
$151M
$6K ﹤0.01%
+656
New +$6.74K
XIN
4317
DELISTED
Xinyuan Real Estate
XIN
$6K ﹤0.01%
+301
New +$6.24K
XME icon
4318
State Street SPDR S&P Metals & Mining ETF
XME
$4.52B
$6K ﹤0.01%
237
-16,071
-99% -$380K
XT icon
4319
iShares Future Exponential Technologies ETF
XT
$3.99B
$6K ﹤0.01%
+118
New +$5.64K
PMD
4320
DELISTED
Psychemedics Corporation
PMD
$6K ﹤0.01%
1,270
+1,190
+1,488% +$5.8K
YTEN
4321
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$6K ﹤0.01%
+30
New +$4.43K
MDVL
4322
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$6K ﹤0.01%
+8
New +$6.84K
ATCX
4323
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$6K ﹤0.01%
666
-11,334
-94% -$94.5K
OBSV
4324
DELISTED
ObsEva SA Ordinary Shares
OBSV
$6K ﹤0.01%
+2,588
New +$7.39K
BIOR
4325
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$6K ﹤0.01%
+3
New +$6.79K

Similar funds

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.